VERAVera Therapeutics, Inc.
What is the market doing?
The market is leaning against it: in a downtrend (−23% vs 200-day) and a crowded short (+24% of shares).
In a downtrend, below its 50- and 200-day averages. Oversold (RSI 30). Price is −23% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).
A crowded short, settled Sep 15, 2026, about a week of normal trading to cover. Down 14% since the previous count, up from 16.6% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How VERA is trading
Vera Therapeutics, Inc. is +17% over the past year while the S&P 500 is +18%: 1.6 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −23%
vs 200-day average · a clear downtrend
- RSI (14)
- 30
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 46%
Below its 52-week high
Details›
- Last close2026-10-09
- $29.87
- 1 monthS&P 500 +2.7%
- −11%
- 1 yearS&P 500 +18%
- +17%
- 5 yearsS&P 500 +88%
- +10.0%
- vs 50-day average$32.71
- −8.7%
- 52-week high
- $55.67
- 52-week low
- $24.10
- Annualised volatility
- 79%
| Year | Return |
|---|---|
| 2026 (year to date) | −41% |
| 2025 | +20% |
| 2024 | +175% |
| 2023 | −21% |
| 2022 | −28% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 5 | 1 of 5 | +5.8% |
| Feb | 5 | 2 of 5 | +1.6% |
| Mar | 5 | 2 of 5 | −4.8% |
| Apr | 5 | 0 of 5 | −10% |
| May | 5 | 1 of 5 | −4.9% |
| Jun | 6 | 3 of 6 | +16% |
| Jul | 6 | 4 of 6 | +8.5% |
| Aug | 6 | 4 of 6 | +2.0% |
| Sep | 6 | 3 of 6 | +6.5% |
| Oct | 6 | 1 of 6 | −7.2% |
| Nov | 5 | 4 of 5 | +29% |
| Dec | 5 | 3 of 5 | +7.8% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.